Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mannatech prevails over Glycoproducts

This article was originally published in The Tan Sheet

Executive Summary

A federal judge rules Glycomannan by Glycoproducts International infringed on multiple patents held by Coppell, Texas-based Mannatech, according to Mannatech. The ruling by the U.S. District Court for the Northern District of Texas also entered a broad permanent injunction against Riggins, Idaho-based Glycoproducts to make, use or sell Glycomannan in the U.S., Mannatech says July 11. Mannatech sought the injunction following a trial jury ruling that Glycoproducts had only infringed one of two patents for Mannatech's Ambrotose glyconutrient supplement (1"The Tan Sheet" June 16, 2008, In Brief)...

You may also be interested in...

Mannatech wins patent suit

As result of litigation to protect its patented glyconutrient products Ambrotose complex and Advanced Ambrotose formulas, the Coppell, Texas-based dietary supplements marketer announces that the U.S. District Court for the Northern District of Texas entered a final judgment and permanent injunction against Boston Mountain Laboratories, banning the firm from making or selling certain products for the duration of several of Mannatech's U.S. patents. Specifically, Boston Mountain Labs cannot sell BML Glyconutrient Formula, Glyco-8 and Glycoessentials, among others. Last year, the firm won patent and trademark claims it brought against Glycobiotics International for its infringing product Glycomannan (1"The Tan Sheet" July 21, 2008)

Mannatech, Glycoproducts split decision

A federal court jury rules in favor of Glycoproducts International regarding infringement of one Mannatech patent in its Glycomannan product, but found the Riggins, Idaho-based firm infringed on a second patent for Mannatech's Ambrotose glyconutrient supplement. The jury in the U.S. District Court for the Northern District of Texas affirmed Mannatech's claim that Glycoproducts infringed on its Ambrotose trademark, the firms say May 28. Coppell, Texas-based Mannatech will pursue an injunction prohibiting Glycoproducts from producing and selling Glycomannan, as well as the reimbursement of its legal fees. Glycoproducts will oppose the injunction request...

UNPA On Team Awarded $300,000 US Grant For Project To Improve Natural Health Trade With China

Grant from Department of Commerce Market Development Cooperator Program funds project for four years. In addition to grant, the project partners – UNPA, National Animal Supplement Council, Eurofins Scientific testing company and China Inspections and Testing Society – get DoC assistance.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts